Photobiomodulation Laser Therapy for COVID-19 Positive Patients With Pulmonary Disease

Multiwave Locked System (MLS) Laser Therapy for COVID-19 Positive Patients With Pulmonary Disease

The aim of this study is to evaluate the effectiveness of MLS laser therapy as a treatment for pulmonary complications due to COVID-19 infection.

Participants will be randomized into treatment vs. control group. Both groups will receive regular inpatient medical treatment. Participants in the experimental arm will receive laser treatments once daily for 4 days. Treatments will be delivered to the patients in a prone position using a 10 by 25 cm laser field across each lung with 7j/cm2 at 1500 Hz. Standard nursing protocols would be used to identify participant's pulmonary status throughout treatment.

Inclusion Criteria:

• COVID-19 positive
• Pulmonary compromise requiring oxygen support of approximately 2-6 liters
• Able to self prone, or support in self-sitting position

Exclusion Criteria:

• Ventilator management
• Patients with autoimmune disorders or inflammatory conditions not related to COVID-19
• Pregnant women